AT302278B - Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze - Google Patents

Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze

Info

Publication number
AT302278B
AT302278B AT344070A AT344070A AT302278B AT 302278 B AT302278 B AT 302278B AT 344070 A AT344070 A AT 344070A AT 344070 A AT344070 A AT 344070A AT 302278 B AT302278 B AT 302278B
Authority
AT
Austria
Prior art keywords
amides
esters
salts
new
production
Prior art date
Application number
AT344070A
Other languages
English (en)
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2990569A external-priority patent/JPS5010298B1/ja
Priority claimed from JP2990769A external-priority patent/JPS5010299B1/ja
Priority claimed from JP8004269A external-priority patent/JPS5010308B1/ja
Priority claimed from JP10419469A external-priority patent/JPS4939995B1/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Priority claimed from US00206966A external-priority patent/US3821404A/en
Application granted granted Critical
Publication of AT302278B publication Critical patent/AT302278B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT344070A 1969-04-16 1970-04-15 Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze AT302278B (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP2990569A JPS5010298B1 (de) 1969-04-16 1969-04-16
JP2990769A JPS5010299B1 (de) 1969-04-16 1969-04-16
JP3416669 1969-05-02
JP3416769 1969-05-02
JP8004269A JPS5010308B1 (de) 1969-10-03 1969-10-03
JP8004169 1969-10-03
JP10280969 1969-12-19
JP10419469A JPS4939995B1 (de) 1969-12-23 1969-12-23
US2641270A 1970-04-07 1970-04-07
US00206966A US3821404A (en) 1969-04-16 1971-12-10 Phenoxy carboxylic acid derivatives as anti-atherosclerosis agents

Publications (1)

Publication Number Publication Date
AT302278B true AT302278B (de) 1972-10-10

Family

ID=27579824

Family Applications (2)

Application Number Title Priority Date Filing Date
AT784271A AT303015B (de) 1969-04-16 1970-04-15 Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze
AT344070A AT302278B (de) 1969-04-16 1970-04-15 Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT784271A AT303015B (de) 1969-04-16 1970-04-15 Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze

Country Status (9)

Country Link
US (2) US3716583A (de)
AT (2) AT303015B (de)
BE (1) BE748970A (de)
CA (1) CA964273A (de)
CH (2) CH556807A (de)
DK (1) DK128731B (de)
FI (1) FI52570C (de)
FR (1) FR2042333B1 (de)
NL (1) NL139016B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092324A (en) * 1971-05-22 1978-05-30 Sumitomo Chemical Company, Limited Diheterocyclic esters of 4-(1,1-bis-(phenoxy-propionic or -butoyric acid)-cyclohexane)α-methyl substituted
US4008265A (en) * 1971-05-22 1977-02-15 Sumitomo Chemical Company, Limited Novel bisphenoxy carboxylic acid derivatives and their salts
JPS575214B2 (de) * 1972-06-01 1982-01-29
JPS4931651A (de) * 1972-07-20 1974-03-22
JPS5735171B2 (de) * 1973-07-02 1982-07-27
AT353776B (de) * 1973-12-27 1979-12-10 Siegfried Ag Verfahren zur herstellung von neuen alkan- saeuren, deren estern und salzen
CH617417A5 (de) * 1973-12-27 1980-05-30 Siegfried Ag
FR2428629A1 (fr) * 1978-06-14 1980-01-11 Hexachimie Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique
EP0363760A1 (de) * 1988-10-12 1990-04-18 Bayer Ag Aromatische Ether
US5179097A (en) * 1991-06-10 1993-01-12 Angres Isaac A Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
EP1911462A3 (de) 2001-01-26 2011-11-30 Schering Corporation Zusammensetzungen enthaltend einen Sterolabsorptionshemmer
WO2002058732A2 (en) * 2001-01-26 2002-08-01 Schering Corporation Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
BR0206644A (pt) * 2001-01-26 2004-02-25 Schering Corp Combinações de inibidor(es) de absorção de esteróis com agente(s) cardiovascular(es) para o tratamento de condições vasculares
JP2004517916A (ja) * 2001-01-26 2004-06-17 シェーリング　コーポレイション ニコチン酸およびその誘導体ならびにステロール吸収阻害剤の併用、および血管適応症の治療
NZ542090A (en) * 2001-01-26 2006-09-29 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
RS50406B (sr) * 2001-01-26 2009-12-31 Schering Corporation, Upotreba supstituisanih jedinjenja azetidinona za lečenje sitosterolemije
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
AU2002241956A1 (en) * 2001-01-26 2002-08-06 Schering Corporation Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US20030013699A1 (en) * 2001-05-25 2003-01-16 Davis Harry R. Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
BR0212907A (pt) * 2001-09-21 2004-10-13 Schering Corp Métodos para tratamento ou prevenção de inflamação vascular usando inibidor(es) da absorção de esteróis
JP2005504091A (ja) * 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US20040092499A1 (en) * 2002-11-06 2004-05-13 Schering Corporation Methods and therapeutic combinations for the treatment of autoimmune disorders
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1601668B1 (de) * 2003-03-07 2008-08-27 Schering Corporation Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
WO2004081003A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholeterolemia
US7192944B2 (en) * 2003-03-07 2007-03-20 Schering Corp. Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
US20050096307A1 (en) * 2003-11-05 2005-05-05 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
US6998397B2 (en) * 2004-07-23 2006-02-14 Drebsk Comptech, Inc. Method for decreasing cholesterol level in blood
CA2627599A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
EP2134169A2 (de) 2007-03-09 2009-12-23 Indigene Pharmaceuticals Inc. Kombination von metformid-r-(+)-lipoat und antihyperlipidämika für die behandlung von diabetes-hyperglykämie und diabetesbedingte komplikationen
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
AU2016215179B2 (en) 2015-02-06 2021-02-25 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions for combination therapy
CN104610051A (zh) * 2015-03-02 2015-05-13 北京万全德众医药生物技术有限公司 一种制备克利贝特杂质的方法
WO2020243590A1 (en) 2019-05-30 2020-12-03 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2444594A (en) * 1947-08-07 1948-07-06 American Cyanamid Co Isopropylidene-p-phenoxy-2-ethanol-p-phenoxyacetic acid
US2541003A (en) * 1948-08-17 1951-02-06 American Cyanamid Co Process for reacting salts of phenols with halo-alkanoic acid compounds
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
US3169144A (en) * 1960-08-12 1965-02-09 Massarani Elena Anticholesterinemic and antilipaemic agents
GB970969A (en) * 1963-08-15 1964-09-23 Shell Int Research Dicarboxylic acids and their esters and a process for the preparation thereof
FR1380816A (fr) * 1963-11-18 1964-12-04 Ciba Geigy Procédé de préparation de nouveaux acides isobutyriques, entre autres de l'acide alpha-[p-(2-p'-chlorophényl-propyl-[2])-phénoxy]-isobutyrique
US3470234A (en) * 1965-08-23 1969-09-30 Ciba Geigy Corp Diaryl substituted benzocycloalkanes
US3470235A (en) * 1965-11-05 1969-09-30 Eastman Kodak Co Alicyclic bisphenyleneoxydicarboxylic acids,salts and esters
GB1121722A (en) * 1966-03-31 1968-07-31 Ici Ltd New carboxylic acid derivatives
US3630715A (en) * 1968-12-19 1971-12-28 Weston Chemical Corp Alkylene bis (phenoxyacetic acid) derivatives as herbicides
US3755603A (en) * 1970-07-01 1973-08-28 Syntex Corp Biphenylyloxyacetic acids in pharmaceutical compositions

Also Published As

Publication number Publication date
FR2042333A1 (de) 1971-02-12
CH556807A (de) 1974-12-13
BE748970A (fr) 1970-09-16
AT303015B (de) 1972-11-10
NL139016B (nl) 1973-06-15
FR2042333B1 (de) 1973-04-06
US3959484A (en) 1976-05-25
CA964273A (en) 1975-03-11
FI52570B (de) 1977-06-30
DK128731B (da) 1974-06-24
NL7005400A (de) 1970-10-20
CH539012A (de) 1973-08-31
FI52570C (fi) 1977-10-10
US3716583A (en) 1973-02-13

Similar Documents

Publication Publication Date Title
AT302278B (de) Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze
AT358017B (de) Verfahren zur herstellung neuer phenoxyalkan- saeuren, deren ester und salze
AT297701B (de) Verfahren zur Herstellung neuer Bistriazolyl-bisphenyl-methanen und deren Salze
CH536803A (de) Verfahren zur Herstellung neuer Naphthylpropionsäuren
AT299909B (de) Verfahren zur Herstellung von neuen Sulfamylanthranilsäuren sowie deren Salzen und Estern
CH537895A (de) Verfahren zur Herstellung neuer Hydroxycrotonsäuren
AT313255B (de) Verfahren zur Herstellung neuer basischer Ester von substituierten Alkylidenaminooxyalkancarbonsäuren und deren Säureadditionssalze
AT303704B (de) Verfahren zur Herstellung neuer Benzylidenaminooxyalkancarbonsäuren und deren Salze und Ester
AT314518B (de) Verfahren zur Herstellung neuer α-Phenylfettsäuren und ihrer Ester, Amide und Salze
AT310757B (de) Verfahren zur Herstellung von neuen Cinnolincarbonsäureestern und von deren pharmazeutisch zulässigen Salzen
AT303709B (de) Verfahren zur Herstellung von neuen substituierten Alkensäuren und deren Salzen, Alkylestern oder Amiden
AT297691B (de) Verfahren zur Herstellung neuer 4-Phenylbuttersäuren und deren Derivate
AT301773B (de) Verfahren zur Herstellung neuer Ester des Fluocinolon-acetonids
AT305255B (de) Verfahren zur Herstellung von neuen Anthranilsäuren und deren Salzen und Estern
CH523862A (de) Verfahren zur Herstellung neuer bis-Phenoxyessigsäuren und deren Estern
AT291292B (de) Verfahren zur Herstellung von neuer Propenyl-phosphonsäure und deren Estern und Salzen
AT313882B (de) Verfahren zur Herstellung neuen substituierten Zimtsäuren und deren Estern, Amiden oder Salzen
AT314512B (de) Verfahren zur Herstellung neuer α-[(1-Cycloalkenyl)-phenoxy]- alkansäuren sowie ihrer Ester, Amide und/oder Salze
AT308110B (de) Verfahren zur Herstellung von Fluorescein-monocarbonsäureestern und deren Salzen
CH555808A (de) Verfahren zur herstellung von l-alpha-hydrazino-betaphenylalkansaeuren, deren salzen und estern.
CH467797A (de) Verfahren zur Herstellung neuer, basisch substituierter Xanthen-9-ol-9-carbonsäureester und deren Salzen
AT308078B (de) Verfahren zur Herstellung von Zimtsäuren und deren Estern
AT280249B (de) Verfahren zur Herstellung neuer basischer Ester und deren Salze
AT314520B (de) Verfahren zur Herstellung neuer α-Phenylfettsäuren und ihrer Ester, Amide und Salze
AT314514B (de) Verfahren zur Herstellung neuer α-[(1-Cyclohexenyl)-phenoxy]- alkansäuren und ihrer Ester, Amide und Salze